A42 HETEROGENEITY IN EFFICACY AND SAFETY ENDPOINTS FOR PEDIATRIC CLINICAL TRIALS IN INFLAMMATORY BOWEL DISEASE: A NEED FOR HARMONIZATION. (21st February 2022) - Crowley, E
Abstract: NOT PUBLISHED AT AUTHOR'S REQUEST Funding Agencies : None